Tedeschi A, Asero R, Lorini M, Marzano A V, Cugno M
Allergy and Clinical Immunology Unit, IRCCS Ca' Granda Foundation, Maggiore Policlinico Hospital, Milan, Italy.
Eur Ann Allergy Clin Immunol. 2012 Oct;44(5):188-92.
Eotaxin is a potent agonist for CC chemokine receptor 3 that can attract eosinophils at sites of inflammation. Given the potential role of eosinophils in chronic spontaneous urticaria (CU), we measured serum eotaxin levels together with C-reactive protein in 100 CU patients who were characterized according to autologous serum skin test (ASST) and disease severity. Serum eotaxin concentration was significantly higher in CU patients (median 140.1 pg/ml, range 33.7-718.7 pg/ml) than in 45 healthy controls (median 108.9 pg/ml, range 45.5-409.4 pg/ml) (p = 0.032) Serum eotaxin concentration was not significantly different in ASST-positive and ASST-negative patients as well as in patients with different urticaria activity scores. However, eotaxin levels tended to be higher in patients with intense symptoms. In the 7 patients observed during CU exacerbation and during remission, eotaxin serum levels tended to decrease during remission, although statistical significance was not reached (median concentration decreased from 170.0 pg/ml to 123.8 pg/ml). CRP levels were not significantly different in CU patients and healthy subjects, although there was a trend towards higher levels in the former population. Furthermore, in the 7 patients observed during CU exacerbation and during remission, CRP levels decreased significantly during remission (median concentration dropped from 4.1 microg/ml to 0.7 microg/ml, p = 0.015). No significant correlation was found between eotaxin and CRP serum levels. These findings indicate that serum eotaxin levels are increased in CU patients, although they do not reflect strictly disease activity. A role for eotaxin in eosinophil attraction and activation in CU can be envisaged.
嗜酸性粒细胞趋化因子是CC趋化因子受体3的强效激动剂,可在炎症部位吸引嗜酸性粒细胞。鉴于嗜酸性粒细胞在慢性自发性荨麻疹(CU)中的潜在作用,我们检测了100例CU患者的血清嗜酸性粒细胞趋化因子水平以及C反应蛋白水平,并根据自体血清皮肤试验(ASST)和疾病严重程度对患者进行了分类。CU患者的血清嗜酸性粒细胞趋化因子浓度(中位数140.1 pg/ml,范围33.7 - 718.7 pg/ml)显著高于45名健康对照者(中位数108.9 pg/ml,范围45.5 - 409.4 pg/ml)(p = 0.032)。ASST阳性和ASST阴性患者以及不同荨麻疹活动评分的患者血清嗜酸性粒细胞趋化因子浓度无显著差异。然而,症状严重的患者嗜酸性粒细胞趋化因子水平往往更高。在7例观察到CU病情加重期和缓解期的患者中,缓解期嗜酸性粒细胞趋化因子血清水平有下降趋势,尽管未达到统计学显著性(中位数浓度从170.0 pg/ml降至123.8 pg/ml)。CU患者和健康受试者的CRP水平无显著差异,尽管前者人群有升高趋势。此外,在7例观察到CU病情加重期和缓解期的患者中,缓解期CRP水平显著下降(中位数浓度从4.1μg/ml降至0.7μg/ml,p = 0.015)。未发现嗜酸性粒细胞趋化因子与CRP血清水平之间存在显著相关性。这些发现表明,CU患者血清嗜酸性粒细胞趋化因子水平升高,尽管它们并不严格反映疾病活动。可以设想嗜酸性粒细胞趋化因子在CU中嗜酸性粒细胞的吸引和激活中发挥作用。